News

NovAliX will discover specific small molecule lead candidates for a novel, validated osteoarthritis target chosen by Galapagos, under the collaboration. The company will identify hits using its Graffinity

The study evaluated the efficacy and safety of the 10mg dose of macitentan or placebo in 178 patients with idiopathic pulmonary fibrosis. On average, patients were exposed to

In the phase I clinical study, comprising a total of 60 healthy volunteers, Matrix M demonstrated positive results. The study was conducted at The Gade Institute, University of

When compared with Japanese Pharmacopoeia-listed pancreatin, the titer per unit weight of Lipacreon is approximately 8 times that of lipase, approximately 7 times that of protease and approximately

Swedish Orphan Biovitrum (SOBI) will now take up the exclusive distribution rights in these countries, extending its territories for Ruconest to all European Union countries, Iceland, Norway and

Mirabegron is a once daily oral selective B3-adrenoceptor agonist discovered and developed by Astellas. The company is seeking approval for the indication of overactive bladder (OAB) associated with

The company is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities

The FDA approval is based on data from 255 patients with locally advanced or metastatic ALK-positive NSCLC across 2 multi-center, single-arm studies, including a Phase 2 study (Profile

The manufacturing facility is the third location, besides New Jersey and Los Angeles facilities, at which Dendreon will produce Provenge (sipuleucel-T). The Atlanta facility includes 36 workstations, and